FFA
LXRX icon

Farther Finance Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Farther Finance Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Sell
2
-253
-99% -$493 ﹤0.01% 5946
2026
Q1 		$418 Sell
255
-2,500
-91% -$3.63K ﹤0.01% 5310
2025
Q4 		$3.17K Buy
2,755
+1,500
+120% +$2.06K ﹤0.01% 4510
2025
Q3 		$1.69K Buy
1,255
+253
+25% +$287 ﹤0.01% 4195
2025
Q2 		$948 Buy
1,002
+1,000
+50,000% +$648 ﹤0.01% 3913
2025
Q1 		$1 Hold
2
– – ﹤0.01% 4256
2024
Q4 		$1 Hold
2
– – ﹤0.01% 3995
2024
Q3 		$3 Hold
2
– – ﹤0.01% 3971
2024
Q2 		$3 Hold
2
– – ﹤0.01% 3803
2024
Q1 		$5 Hold
2
– – ﹤0.01% 3577
2023
Q4 		$3 Buy
+2
New +$2 ﹤0.01% 3536

Other funds holding LXRX

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FGA
Fortis Group Advisors Westwood, New Jersey $626M AUM 33.6% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Farther Finance Advisors's LXRX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Lexicon Pharmaceuticals (LXRX) stake by 99% in Q2 2026, selling an estimated $493 and leaving 2 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #5946.

Farther Finance Advisors first reported a position in LXRX in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.17K in Q4 2025. 10 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Farther Finance Advisors held 2 shares of Lexicon Pharmaceuticals worth $5 as of Q2 2026.
  • Farther Finance Advisors sold 253 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $493.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5946 holding.
  • Farther Finance Advisors first reported a position in Lexicon Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Lexicon Pharmaceuticals position peaked at $3.17K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.